morphosys.com (MOR) Cash Funds Calculated per Share

Symbol and logo of brand MorphoSys Corporation (MOR)

MorphoSys AG generates revenue from royalties on antibody sales through partnerships with major pharmaceutical behemoths. Its environmental policy is based on strict bio-waste disposal and logistics optimization. Patent protection of developments and regulatory support create a high barrier to entry. The trend in cash per share reflects liquidity management, where 4.50 represents the current metric value.

MOR MorphoSys Corp: Cash Funds per Share in the range 07/04/2022 - 08/10/2024

Comprehensive metric breakdowns and analytics for morphosys.com (MOR)

- market price and analyst price targets:
- cash and cash flow data:
Summary company analysis:MOR - MorphoSys Corporation
Flagship merchandise of MorphoSys AG

An objective valuation of MorphoSys AG requires a deep fundamental analysis of liquidity. This indicator determines the volume of actual cash available per ordinary share. By analyzing the cash per share valuation, an investor can discern the business's financial strength reserve. For the biotechnology sector, this reserve is critical for financing antibody development and supporting Monjuvi sales. A stable level of this metric confirms the issuer's ability to drive innovation without the risk of bankruptcy.

Analysis of competing companies

Cash Funds per Single Share ONC (BeiGene Corp)|Cash per Single Share HALO (Halozyme Therapeutics, Inc.)|Cash per Share Revolution Medicines, Inc. (RVMD)|Cash per Share AAPG (ascentage.com)|CG Oncology Inc (CGON) - Cash on Hand per Share|URGN - Cash Funds per Share|Bicara Bio - Cash Calculated per Single Share|PSNL: Cash per Share|Cash Funds per Single Share ERAS|Cash per Single Share DCTH|Cash on Hand per Share Y-mAbs Therapeutics Inc YMAB|Cash per Share AURA|CADL (Candel Therapeutics, Inc.) - Amount of Cash per Share|Cash Funds per Share Accuray Inc ARAY|Cash Funds Calculated per Share SELLAS Life Sciences Group Inc. (SLS)|actuatetherapeutics.com - Cash per Share|Cash on Hand per Share Citius Oncology|HURA: Cash per Share|Cash Money per Share TARA (Protara)|FATE (fatetherapeutics.com) - Cash per Share|Cash on Hand per Share Aadi Bioscience WHWK|Cash per Share TCRX|CSBR - Cash on Hand per Share|XBiotech - Cash per Single Share|CEL-SCI Corporation (CVM) - Cash on Hand per Share|OSTX - Cash Funds per Share|Cash on Hand per Share Radiopharm Theranostics Ltd|ARTV (artivabio.com) - Cash per Single Share|ANL (Adlai Nortye Ltd) - Cash Funds per Share|Cash per Single Share VERU|Tempest Therapeutics (TPST) - Cash Funds Calculated per Share|Cash per Share XLO|Cash per Single Share Renovaro RENB|Cash per Share MURA (Mural Oncology PLC)|KAPA - Cash per Single Share|OnKure Therapeutics - Cash per Share|w2.cytomed.sg - Cash Calculated per Single Share|Curis Corp (CRIS) - Cash Funds per Share|Cash on Hand per Share Apollomics Corp (APLM)|Cash Funds per Share Tharimmune|Cash per Share advanbiomed.com|Cash Funds per Share Genprex, Inc (GNPX)|Cash Funds Calculated per Share Calidi Biotherapeutics, Inc.|Cash per Share SBFM (Sunshine Biopharma Inc.)|XBIO - Cash per Single Share|SLRX: Cash per Single Share|Amount of Cash per Share PPBT (Purple Biotech Ltd.)|AONC: Cash per Share|Cash on Hand per Share BeOne Medicines (BGNE)|Cash Funds per Share Checkpoint Therapeutics, Inc.|Cash per Single Share Elevation Oncology (ELEV)|Cash Funds per Share iCAD Corp (ICAD)|Cash per Single Share Ikena IKNA|Cash per Share NTBL (notablelabs.com)|VIRX - Cash per Single Share|NAYA Biosciences Corp - Cash per Share|Cash on Hand per Share ascentage.com